BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
-21.24%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$9.48B
AUM Growth
+$9.48B
(-21%)
Cap. Flow
+$482M
Cap. Flow
% of AUM
5.09%
Top 10 Holdings %
Top 10 Hldgs %
78.76%
Holding
139
New
5
Increased
29
Reduced
8
Closed
5
Top Buys
1 |
Incyte
INCY
|
$292M |
2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$208M |
3 |
Acadia Pharmaceuticals
ACAD
|
$104M |
4 |
BioMarin Pharmaceuticals
BMRN
|
$57M |
5 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$56.1M |
Top Sells
1 |
DYAX
DYAX CORPORATION
DYAX
|
$313M |
2 |
Gilead Sciences
GILD
|
$25.3M |
3 |
MDVN
MEDIVATION, INC.
MDVN
|
$15.2M |
4 |
WINT
Windtree Therapeutics Inc
WINT
|
$5.54M |
5 |
Iovance Biotherapeutics
IOVA
|
$3.82M |
Sector Composition
1 | Healthcare | 77.24% |